glp-1 agonists and retained gastric contents at endoscopy How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like THE UNSEEN CONSEQUENCES OF GLUCAGON-LIKE
Description
hazard ratio 1.60, 95% CI 1.37 to 1.87) but not after confounding factors were accounted for (0.91, 0.73 to 1.12)

Read how the new Wegovy pill compares to shots like Ozempic to learn which form might be best for you.

The product also includes BCAAs, which not only support muscle endurance but also contribute to a healthier gut environment by supporting digestive health

Safe, drug-free, non-GMO, USA-made

The responsible message: Substantial weight loss usually includes some loss of lean tissue

GLP-1 patches contain no GLP-1 drugs
